Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,582.56
-36.8662-2.28%
Number of Gainers:- -
Number of Losers:7
Number of Flat:- -
PE:- -
High:1,618.99
Open:1,618.99
Low:1,555.04
Close:1,619.43
Volume:37.23M
Turnover:3.69B
Market Cap:1.64T
Float Cap:1.59T

Loading ...

Nurix Therapeutics Announces Achievement of $7 Million Milestone Under Strategic Collaboration with Pfizer

THOMSON REUTERS
·
Sep 29

Lilly Touts Foundayo Advantage over Novo's Ozempic Pill in Diabetes Analysis

Reuters
·
Sep 29

Novo Nordisk Says Ozempic Shows Lower Risk of Cardiovascular Events Compared to Eli Lilly's Mounjaro

Reuters
·
Sep 29

Novo Nordisk announces retrospective RWE on Ozempic in type 2 diabets

TIPRANKS
·
Sep 29

Eli Lilly announces positive results from study of Foundayo 17.2 mg

TIPRANKS
·
Sep 29

Novo Nordisk Strikes Second Licensing Deal Since Frosty Capital-Markets Day

Dow Jones
·
Sep 29

Pfizer Gets Tax Penalty of 12.6 Million Rupees

Reuters
·
Sep 29

Eli Lilly's Foundayo 17.2 Mg was Associated with 1.5% Greater Weight Loss at 52 Weeks

Reuters
·
Sep 29

Lilly Says Foundayo 17.2 Mg Outperforms Oral Semaglutide 25 Mg on Weight Loss, A1C in Indirect Comparison Study

Reuters
·
Sep 29

Eli Lilly - Foundayo 17.2 Mg Shows 1.5% Greater Weight Loss and 0.3% Greater A1c Reduction at 52 Weeks

THOMSON REUTERS
·
Sep 29

Hengrui Pharma and Novo Nordisk Sign Licensing Agreement for HRS-1596 Project

Stock News
·
Sep 29

Judge Rejects Pfizer, BioNTech, and Moderna Bid to Dismiss Monsanto mRNA Patent Lawsuit

Stock News
·
Sep 29

How Investors May Respond To Pfizer (PFE) ESMO Cancer Data Showcase

Simply Wall St.
·
Sep 29

Viking Therapeutics Raises Capital via Equity and Convertibles

TIPRANKS
·
Sep 29

Viking Therapeutics Closes USD 292.5 Million Convertible Senior Notes Offering

Reuters
·
Sep 29

Option traders moderately bearish in Novo Nordisk with shares down 0.22%

TIPRANKS
·
Sep 29

Teva Wins US FDA Approval for Xgeva Biosimilar Degevma

Reuters
·
Sep 29

Sector Update: Healthcare

MT Newswires Live
·
Sep 29

Pfizer, Moderna Lose Bids to Escape Bayer US mRNA Patent Lawsuit

Reuters
·
Sep 29

Market Chatter: Eli Lilly CEO Plans Larger Deals to Target New Disease Areas

MT Newswires Live
·
Sep 29